PROCEPT Biorobotics Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held on June 9, 2026. The filing details the election of directors, the ratification of the independent auditor, and the advisory vote on executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following proposals were submitted to a vote of security holders:
- Proposal 1 (Election of Directors): All nominees were elected to serve until the 2029 annual meeting.
- Antal Desai: 28,444,121 votes For; 8,511,185 votes Withheld.
- Mary Garrett: 29,150,610 votes For; 7,804,696 votes Withheld.
- Frederic Moll, M.D.: 36,455,610 votes For; 499,696 votes Withheld.
- Proposal 2 (Ratification of Auditor): The selection of PricewaterhouseCoopers LLP for the year ending December 31, 2026, was approved.
- Votes For: 47,328,539
- Votes Withheld: 21,691
- Abstentions: 23,133
- Proposal 3 (Executive Compensation): The non-binding advisory vote on named executive officer compensation was approved.
- Votes For: 26,984,867
- Votes Withheld: 9,924,704
- Abstentions: 45,735
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the total number of shares entitled to vote to contextualize the "Broker Non-Votes" (10,418,057) recorded for director and compensation proposals.
- Confirm the tenure of the newly elected directors, which extends until the 2029 annual meeting.
- Review the Definitive Proxy Statement filed on April 22, 2026, for detailed biographies of the elected directors and the specific compensation metrics approved in Proposal 3.